by Uniseed01 | Feb 3, 2021 | Latest News
Uniseed Investee Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema First patient dosed with an investigational retinal vascular disease eye drop Cambridge, UK; 2nd February 2021 – Exonate, an mRNA therapy company...
by Uniseed01 | Dec 22, 2020 | Latest News
Kinoxis Completes $5M Financing Round and Advances Lead Program Through Key Toxicology Studies • $5m funding round completed with existing shareholders • Successful completion of key pre-clinical toxicology studies • IND meeting and commencement of Phase 1 in first...
by Uniseed01 | Dec 18, 2020 | Latest News
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the...
by Uniseed01 | Dec 17, 2020 | Latest News
Uniseed Investee PERKii launches Sparkling Probiotic Drink Nationally at Coles Express Australian probiotic brand PERKii is excited to launch its new 100% plant-based Sparkling Probiotic Drinks into Coles Express stores nationally. PERKii Sparkling is bottled with 1...
by Uniseed01 | Dec 17, 2020 | Latest News
Uniseed Investee Morse Micro Receives CES 2021 Innovation Award for Its Wi-Fi HaLow Technology CES Award Highlights Morse Micro’s Wi-Fi HaLow Product Leadership Across the IoT Ecosystem December 15, 2020 SYDNEY & IRVINE, Calif–Morse Micro,...
by Uniseed01 | Nov 30, 2020 | Latest News
Uniseed increases stake in Ena Respiratory 30 NOVEMBER 2020: Uniseed, a venture fund operating at leading Australian universities, has increased its stake in Australian biotechnology company Ena Respiratory which is developing a potentially landmark preventive...
Recent Comments